{
  "paper_id": "PMC10990746",
  "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10990746/",
  "figures": {
    "figure_1": {
      "figure_number": "Figure 1",
      "title": "Fig. 1.",
      "caption": "miR-4716–3p and AKT2 3' UTR SNP rs2304186 can promote cancer cell apoptosis, survival, and metastasis.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9107/10990746/c0767f47b48e/gr1.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9107/10990746/c0767f47b48e/gr1.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9107/10990746/c0767f47b48e/gr1.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9107/10990746/c0767f47b48e/gr1.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "fig1",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9107/10990746/c0767f47b48e/gr1.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC10990746/images/figure_1.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9107/10990746/c0767f47b48e/gr1.jpg"
    },
    "figure_2": {
      "figure_number": "Figure 2",
      "title": "Fig. 2.",
      "caption": "AKT2 Association with Blood Cancer\n(A) AKT2 gene expression in blood cancer patients versus healthy controls\n(B) Relative expression of AKT2 gene in different types of blood cancer patients.\n(C) Relative expression of AKT2 gene in leukemia sub-types\n(D) Relative expression of AKT2 gene in lymphoma types.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9107/10990746/461540844fc9/gr2.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9107/10990746/461540844fc9/gr2.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9107/10990746/461540844fc9/gr2.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9107/10990746/461540844fc9/gr2.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "fig2",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9107/10990746/461540844fc9/gr2.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC10990746/images/figure_2.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9107/10990746/461540844fc9/gr2.jpg"
    },
    "figure_3": {
      "figure_number": "Figure 3",
      "title": "Fig. 3.",
      "caption": "Association of miRNA-4716-3p with Blood Cancer\n(A) Relative expression of microRNA- 4716–3p in Blood Cancer Patients and Controls\n(B) microRNA-4716–3p expression levels in different types of blood cancer\n(C) Relative expression of microRNA- 4716–3p in leukemia sub-types\n(D) Expression of microRNA-4716–3p in lymphoma types.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9107/10990746/084dac510f5a/gr3.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9107/10990746/084dac510f5a/gr3.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9107/10990746/084dac510f5a/gr3.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9107/10990746/084dac510f5a/gr3.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "fig3",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9107/10990746/084dac510f5a/gr3.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC10990746/images/figure_3.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9107/10990746/084dac510f5a/gr3.jpg"
    },
    "figure_4": {
      "figure_number": "Figure 4",
      "title": "Fig. 4.",
      "caption": "miR-4716–3p and AKT2 gene Diagnostic Value Analysis.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9107/10990746/0e1ccaee82e0/gr4.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9107/10990746/0e1ccaee82e0/gr4.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9107/10990746/0e1ccaee82e0/gr4.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9107/10990746/0e1ccaee82e0/gr4.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "fig4",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9107/10990746/0e1ccaee82e0/gr4.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC10990746/images/figure_4.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9107/10990746/0e1ccaee82e0/gr4.jpg"
    }
  },
  "claims": [
    {
      "sentence": "The AKT2 gene 3′ UTR contains the SNP rs2304186, which, when mutated, prevents miRNA-4716–3p from binding (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The AKT2 gene 3′ UTR contains the SNP rs2304186, which, when mutated, prevents miRNA-4716–3p from binding (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "AKT2 gene association with blood cancer\nThe student t-test was applied for the statistical evaluation showed the relative AKT2 gene mRNA expression was significantly upregulated (p = 0.0034) in the patient's cohort compared to healthy individuals (Fig. 2A).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "ANOVA-based analysis showed a non-significant downregulation of AKT2 gene expression in myeloma compared to leukemia and lymphoma (p = 0.3742) (Fig. 2B).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The results revealed a significant upregulation of the AKT2 gene in AML patients (p = 0.0280) compared to ALL, CLL, and CML (Fig. 2C).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The student t-test results revealed a non-significant upregulation of AKT2 gene expression in NHL patients (p = 0.7527) compared to HL patients (Fig. 2D).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel D",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel D",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel D",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The student t-test was applied for the statistical evaluation showed the relative AKT2 gene mRNA expression was significantly upregulated (p = 0.0034) in the patient's cohort compared to healthy individuals (Fig. 2A).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "ANOVA-based analysis showed a non-significant downregulation of AKT2 gene expression in myeloma compared to leukemia and lymphoma (p = 0.3742) (Fig. 2B).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel B",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The results revealed a significant upregulation of the AKT2 gene in AML patients (p = 0.0280) compared to ALL, CLL, and CML (Fig. 2C).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The student t-test results revealed a non-significant upregulation of AKT2 gene expression in NHL patients (p = 0.7527) compared to HL patients (Fig. 2D).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel D",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel D",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel D",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Association of miRNA-4716–3p with blood cancer\nMicroRNA-4716–3p expression levels were significantly downregulated (p = 0.0294) in patients compared to healthy controls (Fig. 3A).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "ANOVA analysis showed that microRNA-4716–3p expression was non-significantly downregulated (p = 0.2637) in myeloma compared to leukemia and lymphoma (Fig. 3B).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "In contrast to ALL, AML, and CML, microRNA-4716–3p expression showed a non-significant downregulation in CLL patients (p = 0.2137) (Fig. 3C).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "However, in lymphomas, there was significant downregulation (p = 0.0038) of microRNA-4716–3p expression in HL patients compared to NHL patients (Fig. 3D).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel D",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel D",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel D",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "MicroRNA-4716–3p expression levels were significantly downregulated (p = 0.0294) in patients compared to healthy controls (Fig. 3A).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel A",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "ANOVA analysis showed that microRNA-4716–3p expression was non-significantly downregulated (p = 0.2637) in myeloma compared to leukemia and lymphoma (Fig. 3B).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel B",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "In contrast to ALL, AML, and CML, microRNA-4716–3p expression showed a non-significant downregulation in CLL patients (p = 0.2137) (Fig. 3C).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel C",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "However, in lymphomas, there was significant downregulation (p = 0.0038) of microRNA-4716–3p expression in HL patients compared to NHL patients (Fig. 3D).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel D",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel D",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel D",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "3.4. miRNA-4716–3p and AKT2 gene diagnostic value\nROC curve analysis was used to evaluate the diagnostic power of miRNA-4716–3p and its target AKT2 gene (Fig. 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "ROC curve analysis was used to evaluate the diagnostic power of miRNA-4716–3p and its target AKT2 gene (Fig. 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    }
  ],
  "extraction_stats": {
    "figures_count": 4,
    "claims_count": 20,
    "images_downloaded": 4,
    "tables_filtered": 28
  }
}